PUBLISHED THU, JUL 13 202312:43 PM EDT UPDATED THU, JUL 13 20236:57 PM EDT
KEY POINTS
- The Biden administration urged Pfizer, Moderna and Novavax to price their updated Covid vaccines at a “reasonable” rate when they roll them out in the U.S. this fall.
- None of the three manufacturers have disclosed the exact pricing of their single-strain vaccines, which are being designed to target the circulating omicron subvariant XBB.1.5.
- The price points for the shots will be crucial in the fall, as the federal government is expected to shift Covid vaccine distribution to the commercial market.
Skip to content